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INTRODUCTION:  Central  papillary  cystadenocarcinoma  of  the jaw  is  an extremely  rare  tumor  with only
three  previously  reported  cases  in  the English  literature.  This  tumor  is  a histologically  low-grade  cancer,
affecting  more  commonly  in  the  mandible  than in the  maxilla.
PRESENTATION OF  CASE:  A  65-year-old  woman  presented  with  a two  months  history  of  a rapidly  growing,
painless  mass  of  the right  ascending  ramus  of  the  mandible.  The  pathologic  report  from  incisional  biopsy
was  a papillary  cystic  tumor  with  a differential  diagnosis  of  cystadenoma  versus  cystadenocarcinoma.
Segmental  mandibulectomy,  parotidectomy  and  submandibular  gland  resection  were  performed.  The
ﬁnal  pathology  was  intraosseous  papillary  cystadenocarcinoma.
DISCUSSION: Clinical  features  of  central  papillary  cystadenocarcinoma  of  the  mandible  mimic  an  odon-
togenic  lesion  and  metastatic  bone  disease,  careful  review  of radiograph  and  pathology  should  be  done.
Surgical  excision  with  wide  margins  is  the  appropriate  treatment.  Postoperative  radiation  therapy  should
be  considered  in histologically  aggressive  or high-stage  tumor.
CONCLUSION: This  is  the  fourth  case  of central  papillary  cystadenocarcinoma  of  the  mandible  in the
English  literature.  Although  it is  usually  a low-grade  cancer,  en bloc  resection  with  adjuvant  postoperative
radiotherapy  in  a  high-stage  disease,  and  long-term  follow-up  allow  the  patient  to  have  a favorable
prognosis.
©  2014  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
he CCaccess article  under  t
. Introduction
Malignant salivary gland neoplasms that occur primarily in
he mandible are rare, with most of them being mucoepidermoid
arcinoma.1,2 Papillary cystadenocarcinoma of the salivary gland
s uncommonly found3 and when it originates intraosseously in
he mandible, only three cases have been previously reported.2,4,5
istologically, the tumor is characterized by a predominantly
ystic and invasive growth pattern with a papillary component
nd deﬁned as a low-grade malignant glandular tumor.3,6 The
adiologic ﬁnding consists of a unilocular or multilocular radiolu-
ency mandibular lesion which mimics an odontogenic lesion and
etastatic bone disease.2,4 The authors report the fourth case, and
iscuss clinical features and management of central papillary cys-
adenocarcinoma of the mandible.
∗ Corresponding author at: Head and Neck Surgery Unit, Department of Otolaryn-
ology,  Faculty of Medicine, Chiang Mai  University, Chiang Mai, Thailand.
el.: +66 53945562; fax: +66 53945564.
E-mail address: psittitrai@yahoo.com (P. Sittitrai).
ttp://dx.doi.org/10.1016/j.ijscr.2014.04.006
210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical A
http://creativecommons.org/licenses/by-nc-nd/3.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
2. Presentation of case
A  65-year-old woman  presented with a two months history of
a rapidly growing, painless mass of the right face without tris-
mus, facial or trigeminal neuropathy, or other neck mass. Her
history included controlled hypertension and a left thyroid lobec-
tomy for toxic adenoma several years ago. Physical examination
revealed a hard consistency mass about 7 cm × 7.5 cm over the right
mandibular ramus (Fig. 1). Fine needle aspiration biopsy (FNAB)
was performed but the result was unsatisfactory. Computed tomo-
graphy scan showed a large multilocular low density area at the
ascending ramus of the mandible attached to the parotid gland and
an ill-deﬁned border between submandibular gland and the mass
(Fig. 2). An open incisional biopsy was performed and the patholog-
ical report was  a papillary cystic tumor with a differential diagnosis
of cystadenoma versus cystadenocarcinoma.
Segmental mandibulectomy, parotidectomy and submandi-
bular gland resection were performed (Fig. 3). Neck dissection was
not performed because no lymphadenopathy was detected in CT
scan. The ﬁnal pathology was  intraosseous papillary cystadeno-
carcinoma of the mandible with both major salivary glands being
normal tissue. Microscopically, the tumor contained multiple cystic
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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Fig. 2. Axial non-contrast enhanced CT scan of the mandibular ramus shows a cir-
cumscribed margin, multilocular cystic mass at the right side with internal coarse,
irregular calciﬁcations (A). Bone window image reveals a very thin bone around the
expansile mass (B). The tumor has contact surface with the right parotid gland and
caused lateral displacement of the gland in a contrast enhanced ﬁlm (C).Fig. 1. A 65-year-old woman with a hard consistency mass at right mandible.
avities with papillary projection. The neoplastic ducts inﬁltrate
nto the bone and surrounding skeletal muscle. The lining epithe-
ia are mostly single layer of cuboidal cells with mild cellular and
uclear pleomorphism. The mitotic activity is low. The necrosis and
erineural invasion is not present (Fig. 4).
The tumor cells are immunoreactive for CK7, CK19 and CEA but
ot for CDX-1, CK20, CA-125 and TTF-1.
The diagnosis was central papillary cystadenocarcinoma of the
andible. Post-operative radiotherapy with a total dose of 66 Gy
2 Gy per fraction) at the primary site and upper neck (levels I–III)
as administered because of the large tumor size with cortical bone
rosion although the surgical margins were negative and perineural
nvasion and high grade features were absent.
One year after surgery and ten months post-radiation therapy,
he patient has no tumor recurrence both at the primary and neck
Fig. 5).
.  Discussion
Papillary cystadenocarcinoma of the salivary gland described
y the WHO  in 1991 is extremely rare.3,7 The tumor is
lso called malignant papillary cystadenoma, atypical type
f adenocarcinoma, low-grade papillary adenocarcinoma, and
ucous-producing adenopapillary carcinoma.3,8 This tumor is
ore commonly found in the major salivary glands (65%) and most
ften occurs in the parotid gland (95%).6 The minor salivary glands
nvolved by the tumor are found in the lip, buccal mucosa, palate,
ongue and retromolar trigone.6 Tumor histology is characterized
y a cyst and papillary endocystic projection and deﬁned as a low-
rade glandular tumor with an indolent behavior.3,6 However, the
resence of intense nuclear and cellular pleomorphism and numer-
us mitosis with a rapidly progressive clinical course indicate a
igh-grade malignant tumor.3
Central or primary malignant salivary gland neoplasm of the
aw is a rare neoplasm arising intraosseously.1,4,5,9 The tumor is
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Fig. 5. Picture of the patient 1 year after surgery.
F
tFig. 3. Surgical specimen (tumor at ascending ramus of the mandible).
ound more commonly in the mandible than in the maxilla1 and
omprises less than 0.4% of all salivary gland carcinomas.9 Ectopic
alivary gland tissue has been reported in a wide variety of loca-
ions, including the skin of the neck, the thyroid, the pituitary, the
astoid, the middle ear, the maxilla, and the mandible.1,9 Neo-
lasm of the heterotopic salivary tissue is rare and most reported
ases are in the upper cervical lymph node and in the mandible.9
ig. 4. Histopathology of the tumor shows cystic cavities lined with single layer of cuboidal cells with mild nuclear pleomorphism. (A) (H&E stain, 400× magniﬁcation). The
umor’s  immunohistochemical stainings are positive for CK7 (B), CK19 (C) and CEA (D)
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The pathogenesis of salivary gland tumor arising centrally within
the mandible has been proposed as (1) entrapment of salivary tis-
sue from the major or minor salivary glands within bone during
embryonic development, (2) aberrant induction of salivary tissue
from the dental lamina epithelium during embryonic development,
(3) metaplastic transformation of mucous secreting cells in odon-
togenic cyst epithelium, or (4) entrapment of minor salivary glands
from chronic osteomyelitis.1,2,10,11
The most frequent manifestation of the patient is a swelling of
the mandible followed by bony pain or tooth pain, trismus, pares-
thesia of the lip, mobile teeth and drainage.1,2
Unilocular or multilocular radiolucency in a radiograph is char-
acteristic of a central bone lesion,1,2 although it has been reported
that most lesions with unilocular destruction were malignant
changes in odontogenic cysts, and most lesions with multilocular
destruction were intraosseous salivary gland carcinomas.9
The histology of a central salivary gland neoplasm in the
mandible is identical to that of its salivary gland counterparts
and usually does not pose diagnostic difﬁculties.9 The principal
differential diagnosis for this disease is metastasis from another
primary carcinoma and cystic odontogenic lesion.1,2,9 The presence
of intermediate cells and multilocular destruction would favor the
diagnosis of central salivary gland malignancy.9
Pathologic examination of the tumor specimen and imaging
study should be reviewed to exclude the possibility of any con-
nection with the nearby mucosa and salivary gland.9 Histology
and immunostaining are useful for differentiating the disease from
odontogenic, osteogenic and metastatic lesions. The criteria for the
diagnosis of the central origin of salivary gland malignancy in the
mandibles have been introduced as (1) radiographic evidence of
primary central bone destruction, (2) absence of any primary lesion
in the major or minor salivary glands, (3) clinical and histological
exclusion of a metastasis or an odontogenic lesion, and (4) his-
tologic conﬁrmation of the typical architectural and morphologic
features of malignant salivary gland tumors.1,2,11,12
Li et al.2 summarized 197 cases of central malignant salivary
gland tumors of the jaw and stated that mucoepidermoid carcino-
mas were the most common histology (68.5%) followed by adenoid
cystic carcinomas (16.2%), adenocarcinomas, NOS (5.0%), acinic cell
carcinoma (4.6%), carcinoma ex pleomorphic adenoma (4.1%), and
epithelial-myoepithelial carcinoma (1.5%).
A staging system for central malignant salivary gland tumor was
established by Brookstone and Huvos in 1992 based on the condi-
tion of overlying bone. Stage I is indicated by lesions with intact
cortical bone and overlying periosteum without signs of cortical
expansion. In Stage II lesions are surrounded by intact cortical bone
with some degree of expansion. Stage III is characterized by lesions
with cortical perforation, breakdown of the overlying periosteum
or nodal metastasis.1
The appropriate treatment of the primary tumor is en bloc
resection, including marginal mandibulectomy and segmental
mandibulectomy based on preoperative (clinical and radiologic)
Table 1
Summary of central papillary cystadenocarcinoma of the mandible.
Author, year Age (yrs) Gender Location Signs/symptoms 
Johnston et al., 2006 73 F Angle Jaw pain, Resorbed t
Li  et al., 2008 56 F Ramus Painless swelling 
Takei  et al.,
2012
64 F Body  Painful
swelling
Present
report
65 F Ramus Painless
swellingPEN  ACCESS
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ﬁndings and intraoperative evaluation 2 and the authors suggest
a 1–1.5 cm margin of bone resection. Neck dissection is necessary
when evidence of any metastatic cervical lymph node involve-
ment is present.2,11 Adjuvant radiotherapy and chemotherapy have
been reported in cases with perineural invasion, inadequate surgi-
cal margin, large tumor, rupture of cortical plate, and soft tissue
invasion.2,11
Following a literature review of central papillary cystadeno-
carcinoma of the mandible, three cases have been previously
reported.2,4,5 The summary of four cases, including ours, listed
all patients as female. Most presented with painful swelling of
the mandible. Surgery was the primary therapy which was  either
partial mandibular resection/marginal mandibulectomy or seg-
mental mandibulectomy. Neck dissection was  performed in a
case with lymphadenopathy. One case reported tumor recur-
rence after a segmental mandibulectomy which likely reﬂected
an advanced stage of the disease2 (Table 1). Our case, a large
tumor at the mandibular ramus (stage III, Brookstone and Huvos’s
classiﬁcation) underwent segmental mandibulectomy and resec-
tion of submandibular and parotid glands because the tumor
approached these structures. Radiation therapy was administered
postoperatively due to large tumor volume and erosion of cortical
bone plate even though pathology reported free surgical mar-
gins and normal submandibular and parotid glands. There has
been no evidence of tumor recurrence after one year of follow-
up.
4. Conclusion
Central papillary cystadenocarcinoma of the mandible is a low-
grade malignant tumor. Clinical, radiographic and histopathologic
examinations should be carefully reviewed to differentiate this
neoplasm from other possible diseases. The tumor’s prognosis is
still unsettled. Surgical excision with wide margins is the appropri-
ate treatment, while adjuvant radiotherapy should be considered
in histologically aggressive or high stage tumor. Prolonged clinical
observation is mandatory.
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Ethical  approvalTreatment Follow-up
ooth Curettage then marginal mandibulectomy NA
Hemimandibulectomy Recur in 8 mo
Partial resection of mandible No recurrence in 26 mo
Supreomohyoid neck dissection
Segmental  mandibulectomy No  recurrence in 1 yr
Parotidectomy
Submandibular  gland resection
Postoperative radiotherapy
Written informed consent was obtained from the patient for
publication of this case report and accompanying images. A copy
of the written consent is available for review by the Editor-in-Chief
of this journal on request.
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Key learning points
• Central  papillary cystadenocarcinoma of the mandible can mimic  an odontogenic lesion and metastatic bone disease.
• En  bloc resection with adjuvant postoperative radiotherapy is the treatment.
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